Collateral lethality refers to the deletion of genes adjacent to the tumor suppressor genes. These genes though are not involved in cancer progression gets deleted when TSG gets blocked or disabled due to proximity to tumor suppressor genes. These deleted genes act as points of selective vulnerability for developing novel molecular targeted therapeutic strategy.
Know more about this innovative #cancertretament method at #cancertherapy2018 #Internationalconference to be held at #Osaka, Japan during #October 15-16
No comments:
Post a Comment